Combining copy number, methylation markers, and mutations as a panel for endometrial cancer detection via intravaginal tampon collection.

CONCLUSIONS: This study demonstrates a proof-of-principle for non-invasive yet precise detection of endometrial cancer. We propose that with improved biomarker testing, it may be possible to develop a clinically useful test for detecting EC.
PMID: 31787246 [PubMed - as supplied by publisher]

Source: Gynecologic Oncology - November 27, 2019 Category: Cancer & Oncology Authors: Sangtani A, Wang C, Weaver A, Hoppman NL, Kerr SE, Abyzov A, Shridhar V, Staub J, Kocher JA, Voss JS, Podratz KC, Wentzensen N, Kisiel JB, Sherman ME, Bakkum-Gamez JN Tags: Gynecol Oncol Source Type: research